Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gilbert

Showing results (811-820 of 948) with videos related to

Pageof 95
Sort By:
Trials|April 29, 2014
Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trialNicholas J A Webb, Emma Frew, Elizabeth A Brettell, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 26, 2013
Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndromeHugh J McCarthy, Agnieszka Bierzynska, Matt Wherlock, et al.
Neuroscience Research|April 6, 2024
Understanding the human conflict processing network: A review of the literature on direct neural recordings during performance of a modified stroop taskRyan S Chung, Jonathon Cavaleri, Shivani Sundaram, et al.
Dermatology (Basel, Switzerland)|January 20, 2004
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient seraP Joly, Ph Courville, C Lok, et al.
American Journal of Human Genetics|April 9, 2013
Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylationBobby G Ng, Kati J Buckingham, Kimiyo Raymond, et al.
Annales De Dermatologie Et De Venereologie|July 20, 2004
[Relationship between clinical findings of patients with bullous pemphigoid and antigens recognized by their circulating antibasement membrane zone antibodies]A Gary, P Carvalho, J-B Louison, et al.
JAMA Pediatrics|December 20, 2021
Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical TrialMartin T Christian, Nicholas J A Webb, Samir Mehta, et al.
Health Technology Assessment (Winchester, England)|January 21, 2022
Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCTMartin T Christian, Nicholas Ja Webb, Rebecca L Woolley, et al.
Pharmacoeconomics - Open|June 22, 2022
Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based AnalysisNafsika Afentou, Emma Frew, Samir Mehta, et al.
Kidney International|January 25, 2017
Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease managementAgnieszka Bierzynska, Hugh J McCarthy, Katrina Soderquest, et al.
Pageof 95

Showing results (811-820 of 948) with videos related to

Sort By:
Pageof 95
Trials|April 29, 2014
Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trialNicholas J A Webb, Emma Frew, Elizabeth A Brettell, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 26, 2013
Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndromeHugh J McCarthy, Agnieszka Bierzynska, Matt Wherlock, et al.
Neuroscience Research|April 6, 2024
Understanding the human conflict processing network: A review of the literature on direct neural recordings during performance of a modified stroop taskRyan S Chung, Jonathon Cavaleri, Shivani Sundaram, et al.
Dermatology (Basel, Switzerland)|January 20, 2004
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient seraP Joly, Ph Courville, C Lok, et al.
American Journal of Human Genetics|April 9, 2013
Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylationBobby G Ng, Kati J Buckingham, Kimiyo Raymond, et al.
Annales De Dermatologie Et De Venereologie|July 20, 2004
[Relationship between clinical findings of patients with bullous pemphigoid and antigens recognized by their circulating antibasement membrane zone antibodies]A Gary, P Carvalho, J-B Louison, et al.
JAMA Pediatrics|December 20, 2021
Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical TrialMartin T Christian, Nicholas J A Webb, Samir Mehta, et al.
Health Technology Assessment (Winchester, England)|January 21, 2022
Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCTMartin T Christian, Nicholas Ja Webb, Rebecca L Woolley, et al.
Pharmacoeconomics - Open|June 22, 2022
Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based AnalysisNafsika Afentou, Emma Frew, Samir Mehta, et al.
Kidney International|January 25, 2017
Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease managementAgnieszka Bierzynska, Hugh J McCarthy, Katrina Soderquest, et al.
Pageof 95